Evidence-based guideline: Treatment of painful diabetic neuropathy-report of the American association of Neuromuscular and electrodiagnostic medicine, the American academy of Neurology, and the American Academy of physical medicine & Rehabilitation

Muscle and Nerve

Volumn 43, Issue 6, 2011, Pages 910-917

  Bril, Vera ^a   England, John D ^b   Franklin, Gary M ^c   Backonja, Miroslav ^d   Cohen, Jeffrey A ^e   del Toro, David R ^f   Feldman, Eva L ^g   Iverson, Donald J ^h   Perkins, Bruce ^a   Russell, James W ⁱ   Zochodne, Douglas W ^j  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g UNIVERSITY OF MICHIGAN   (United States)

^h Humboldt Neurological Medical Group Inc   (United States)

ⁱ UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF CALGARY   (Canada)

more..

Author keywords

Efficacy; Neuropathic pain; Painful diabetic neuropathy; Quality of life; Treatment options

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZATROPINE; CAPSAICIN; CLONIDINE; DESIPRAMINE; DEXTROMETHORPHAN; DULOXETINE; FLUOXETINE; FLUPHENAZINE; GABAPENTIN; HARKOSERIDE; ISOSORBIDE DINITRATE; LAMOTRIGINE; MAPROTILINE; MEXILETINE; MORPHINE SULFATE; NORTRIPTYLINE; OPIATE; OXCARBAZEPINE; OXYCODONE; PARACETAMOL PLUS TRAMADOL; PENTOXIFYLLINE; PREGABALIN; TOPIRAMATE; TRAMADOL; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE;

ANTICONVULSANT THERAPY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DRUG EFFICACY; ELECTRODIAGNOSIS; ELECTROSTIMULATION; EVIDENCE BASED MEDICINE; HUMAN; LOW LEVEL LASER THERAPY; MAGNETIC FIELD; MAGNETOTHERAPY; NEUROMUSCULAR SYSTEM; NEUROPATHIC PAIN; ORGANIZATION; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHYSICAL MEDICINE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHABILITATION; REIKI; REVIEW;

ANALGESIA; ANALGESICS; COMBINED MODALITY THERAPY; DIABETIC NEUROPATHIES; EVIDENCE-BASED MEDICINE; HUMANS; NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; UNITED STATES;

EID: 79957939198     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.22092     Document Type: Review

References (40)

1. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freedman R, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005;28:956-962.
2. Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 2003;26:1790-1795.
3. Daousi C, MacFarlane IA, Woodward A, Nurmikko TJ, Bundred PE, Benbow SJ. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 2004;21:976-982.
4. Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manage 2003;25:406-411.
5. Farrar JT, Pritchett YL, Robinson M, Prakash A, Chappell A. The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders. J Pain 2010;11:109-118.
6. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94:149-158.
7. Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 2004;63:2104-2110.
8. Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005;6:253-260.
9. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a doubleblind, placebo-controlled trial. Pain 2004;110:623-638.
10. Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible-and fixed-dose regimens. Pain 2005;115:254-263.
11. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998;280:1831-1836.
12. Gorson KC, Schott C, Herman R, Ropper AH, Rand WM. Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial. J Neurol Neurosurg Psychiatry 1999;66:251-252.
13. Eisenberg E, Lurie Y, Braker C, Daoud D, Ishay A. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 2001;57:505-509.
14. Vinik AI, Tuchman M, Safirstein B, Corder C, Kirby L, Quessy M, et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies. Pain 2007;128:169-179.
15. Kochar DK, Jain N, Agarwal RP, Srivastava T, Agarwal P, Gupta S. Sodium valproate in the management of painful neuropathy in type 2 diabetes-a randomized placebo controlled study. Acta Neurol Scand 2002;106:248-252.
16. Kochar DK, Rawat N, Agrawal RP, Vyas A, Beniwal R, Kochar SK, et al. Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study. QJM 2004;97:33-38.
17. Raskin P, Donofrio PD, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, et al. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 2004;63:865-873.
18. Grosskopf J, Mazzola J, Wan Y, Hopwood M. A randomized, placebocontrolled study of oxcarbazepine in painful diabetic neuropathy. Acta Neurol Scand 2006;114:177-180.
19. Dogra S, Beydoun S, Mazzola J, Hopwood M, Wan Y. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. Eur J Pain 2005;9:543-554.
20. Beydoun A, Shaibani A, Hopwood M, Wan Y. Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study. Acta Neurol Scand 2006;113:395-404.
21. Rauck RL, Shaibani A, Biton V, Simpson J, Koch B. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study. Clin J Pain 2007;23:150-158.
22. Wymer JP, Simpson J, Sen D, Bongardt S. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens. Clin J Pain 2009; 25:376-385.
23. Shaibani A, Biton V, Rauck R, Koch B, Simpson J. Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial. Eur J Pain 2009;13:458-463.
24. Rowbotham MC, Goli V, Kunz NR, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a doubleblind, placebo-controlled study. Pain 2004;110:697-706.
25. Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromuscul Dis 2001;3:53-62.
26. Raskin J, Pritchett YL, Wang F, D'souza DN, Waninger AL, Iyengar S, et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005;6:346-356.
27. Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005; 116:109-118.
28. Wernicke JF, Pritchett YL, D'Souza DN, Waninger A, Tran P, Iyengar S, et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006;67:1411-1420.
29. Vrethem M, Boivie J, Arnqvist H, Holmgren H, Lindstrom T, Thorell LH. A comparison of amitriptyline and maprotiline in the treatment of painful diabetic neuropathy in diabetics and nondiabetics. Clin J Pain 1997;13:313-323.
30. Max MB. Endogenous monoamine analgesic systems: amitriptyline in painful diabetic neuropathy. Anesth Prog 1987;34:123-127.
31. Max MB, Culnane M, Schafer SC, Gracely RH, Walther DJ, Smoller B, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987;37: 589-596.
32. Kvinesdal B, Molin J, Froland A, Gram LF. Imipramine treatment of painful diabetic neuropathy. JAMA 1984;251:1727-1730.
33. Gomez-Perez FJ, Rull JA, Dies H, Rodriquez-Rivera JG, Gonzalez-Barranco J, Lozano-Castaneda O. Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind crossover study. Pain 1985;23:395-400.
34. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-1256.
35. Sang CN, Booher S, Gilron I, Parada S, Max MB. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology 2002;96:1053-1061.
36. Nelson KA, Park KM, Robinovitz E, Tsigos C, Max MB. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997;48:1212-1218.
37. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005;352:1324-1334.
38. Harati Y, Gooch C, Swenson M, Edelmen S, Greene D, Raskin P, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998;50: 1842-1846.
39. Sindrup SH, Andersen G, Madsen C, Smith T, Brosen K, Jensen TS. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain 1999;83:85-90.
40. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetiic neuropathy: a randomized controlled trial. Neurology 2003;60:927-934.